Specialty Chemicals · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Debt / 36-month avg market cap | 1.14% | < 33% | Pass |
| Cash + interest-bearing securities / 36-month avg market cap | 3.95% | < 33% | Pass |
| Accounts receivable / 36-month avg market cap | 0% | < 33% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0% of any dividend from DEEPAKNTR should be given to charity. Calculate your amount →
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.
DEEPAKNTR has mixed returns with recent one-month weakness but positive three- and six-month performance, and trades moderately below its 52-week high with a still-supportive moving-average configuration, consistent with consolidation within a broader up-bias. No clear sector sentiment cue is provided.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.